Lundbeck delivers a solid EBIT of DKK 882 million and Vyepti is off to a good start
HIGHLIGHTS Revenue reached DKK 4,273 million in the first quarter of 2021, a decline of 2% in local currencies. EBIT grew 235% compared to the same period in 2020 and reached DKK 882 million. EBIT margin reached 20.6%. EPS grew by 578% in the quarter thereby reaching DKK 3.13. The newest product in the portfolio, Vyepti[®], grew 49% since the fourth quarter of 2020. The brand continues its strong momentum since launch in the second quarter of 2020. Regulatory review is ongoing in 12 markets. Strategic brand performance: · · Revenue of Abilify Maintena[®]: DKK 584 million